Literature DB >> 9831349

X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency.

T Yorifuji1, J Muroi, A Uematsu, K Tanaka, K Kiwaki, F Endo, I Matsuda, H Nagasaka, K Furusho.   

Abstract

Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder. It is X-linked and hemizygous new-born males usually suffer fatal hyperammonemia. In contrast, carrier females manifest variable phenotypes, ranging from asymptomatic carriers to those with severe hyperammonemia. In order to understand the correlation between X-inactivation status and the clinical phenotype of carrier females with this disorder, we analyzed the X-inactivation pattern of peripheral blood leukocytes in a family consisting of a clinically normal mother and two daughters with severe manifestation. In addition, we obtained tissue samples from various parts of the liver of one of these daughters and analyzed X-inactivation patterns and the residual OTC activities. The X-inactivation of peripheral blood leukocytes was nearly random in these carrier females and showed no correlation with the disease phenotype. However, the X-inactivation of the liver was much more skewed and correlated well with the OTC activity of all samples. Interestingly, the degree of X-inactivation varied considerably, even within the same liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831349     DOI: 10.1034/j.1399-0004.1998.5440415.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  23 in total

1.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Symptoms of OTC deficiency but not DMD in a female carrier of an Xp21.1 deletion including the genes for dystrophin and OTC.

Authors:  Sibylle Jakubiczka; Thomas Bettecken; Klaus Mohnike; Reinhard Schneppenheim; Markus Stumm; Holger Tönnies; Marianne Volleth; Peter Wieacker
Journal:  Eur J Pediatr       Date:  2006-11-08       Impact factor: 3.183

Review 3.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

4.  Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency.

Authors:  Dita Musalkova; Eva Sticova; Martin Reboun; Jitka Sokolova; Jakub Krijt; Jitka Honzikova; Jiri Gurka; Magdalena Neroldova; Tomas Honzik; Jiri Zeman; Milan Jirsa; Lenka Dvorakova; Martin Hrebicek
Journal:  Virchows Arch       Date:  2018-04-06       Impact factor: 4.064

5.  Whole Xp Deletion in a Girl with Mental Retardation, Epilepsy, and Biochemical Features of OTC Deficiency.

Authors:  K Joost; P Tammur; R Teek; O Zilina; M Peters; M Kreile; B Lace; R Zordania; I Talvik; K Ounap
Journal:  Mol Syndromol       Date:  2011-09-14

6.  Female heterozygotes for the hypomorphic R40H mutation can have ornithine transcarbamylase deficiency and present in early adolescence: a case report and review of the literature.

Authors:  Jason R Pinner; Mary-Louise Freckmann; Edwin P Kirk; Makoto Yoshino
Journal:  J Med Case Rep       Date:  2010-11-12

7.  Liver Failure as the Presentation of Ornithine Transcarbamylase Deficiency in a 13-Month-Old Female.

Authors:  Farrah Rajabi; Lance H Rodan; Maureen M Jonas; Janet S Soul; Nicole J Ullrich; Ann Wessel; Susan E Waisbren; Wen-Hann Tan; Gerard T Berry
Journal:  JIMD Rep       Date:  2017-09-09

Review 8.  Maternal Genetic Disorders in Pregnancy.

Authors:  Sarah Harris; Neeta L Vora
Journal:  Obstet Gynecol Clin North Am       Date:  2018-06       Impact factor: 2.844

Review 9.  Dosage Compensation in Females with X-Linked Metabolic Disorders.

Authors:  Patrycja Juchniewicz; Ewa Piotrowska; Anna Kloska; Magdalena Podlacha; Jagoda Mantej; Grzegorz Węgrzyn; Stefan Tukaj; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

10.  The role of exome sequencing in newborn screening for inborn errors of metabolism.

Authors:  Jennifer M Puck; Steven E Brenner; Aashish N Adhikari; Renata C Gallagher; Yaqiong Wang; Robert J Currier; George Amatuni; Laia Bassaganyas; Flavia Chen; Kunal Kundu; Mark Kvale; Sean D Mooney; Robert L Nussbaum; Savanna S Randi; Jeremy Sanford; Joseph T Shieh; Rajgopal Srinivasan; Uma Sunderam; Hao Tang; Dedeepya Vaka; Yangyun Zou; Barbara A Koenig; Pui-Yan Kwok; Neil Risch
Journal:  Nat Med       Date:  2020-08-10       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.